A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
| Image |  |
|---|---|
| Description | scientific article published on 07 February 2020 |
| Author/s |
author: Shoji Nagao |
| Publication date | February 7, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |